Page 19 - Flipbook

Satraplatin Phase 3 trial in mCRPC

LHRHa plus oral satraplatin and pred VS LHRHa and pred

• SPARC trial reported 25% PSA response rate in satraplatin arm

Sternberg et al, JCO 2009
No molecular selection